Skip to main content
All lobbying filings

MEDTRONIC, INC.

MEDTRONIC, INC. filed a Q3 report for MEDTRONIC INC on October 20, 2025.

Lobbying for MEDTRONIC INC

All filings by MEDTRONIC, INC. · Everything MEDTRONIC INC has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$2,080,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 12

Issues related to anti-trust and competition

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025

Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances

Issues related to Medicare coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; HR 5343) Issues related to Medicare coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399) Issues related to Medicare Physician Fee Schedule Issues related to H.R. 1, the One Big Beautiful Bill Act Issues related to prior authorization, including CMMI WISeR Model Issues related to DME competitive bidding

Issues related to the taxation of multinational corporations corporations, including provisions of H.R. 1, the One Big Beautiful Bill Act

Issues related to global supply chains including rare earth and critical minerals Issues related to tariffs Issues related to Japan reimbursement

Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 Issues related to artificial intelligence and other advanced software in health care, including provisions of the One Big Beautiful Bill Act Issues related to FDA workforce and product review processes Issues related to H.R. 1, the One Big Beautiful Bill Act Issues related to Parkinsons disease Issues related to diabetes Issues related to epilepsy Issues related to overactive bladder and urinary incontinence

Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015

Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies Issues related to right to repair

Issues related to hypertension Issues related to procurement of healthcare technologies

Issues related to S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 including servicing and repair of medical devices, outbound investment and BIOSECURE

Issues related to hypertension, including FY26 MilCon/Veterans Appropriations

 Bills named in this filing 10
  • S. 1553
    PREVAIL Act
  • S. 1546
    Patent Eligibility Restoration Act of 2025
  • S. 708
    RESTORE Patent Rights Act of 2025
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S. 1399
    Health Tech Investment Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 1539
    Medical Device Electronic Labeling Act
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem